Who do we help after an opiate overdose?

marlon-lara-nShBtdRHlNU-unsplash

Ian Hamilton reviews a recent US study exploring the incidence of treatment for opioid use disorder in people following a non-fatal opiate overdose.

[read the full story...]

Mental health and benefits insecurity

josh-appel-NeTPASr-bmQ-unsplash

Consultant psychiatrist Dr Dieneke Hubbeling critically analyses a recent study looking at mental health benefits insecurity, and concludes that it is important for clinicians to realise that there is probably no such thing as benefits security.

[read the full story...]

Suicide risk in young people who self-harm and visit emergency departments

sharon-mccutcheon-YIjgPO1nLmY-unsplash

Katerina Kavalidou reviews a prospective observational cohort study on mortality and suicide risk in young people after they present to hospital emergency departments following episodes of self-harm.

[read the full story...]

Psychosocial assessment, self-harm repetition and the role of the assessor

kelly-sikkema-tQQ4BwN_UFs-unsplash

Katherine Chartes reviews a cohort study comparing risk of repeat self-harm after psychosocial assessment, which suggests that psychosocial assessments can reduce re-attendance by 30% within a 12-month timeframe.

[read the full story...]

Risk and protective factors for childhood suicide: thoughts, plans and behaviours

shutterstock_742597825

In her debut blog, Ellen Townsend summarises a cohort study that explores the risk and protective factors for childhood suicidal thoughts and behaviours.

[read the full story...]

First episode psychosis in prison: is our screening effective?

tom-blackout-LJp0F9Icjlc-unsplash

Danny Whiting explores the issue of screening for first episode psychosis in prison using a retrospective cohort study from Australia.

[read the full story...]

Survivors of genocide more likely to develop dementia, according to new Israeli study

andrea-nardi-mtJUCgwxBH4-unsplash

Anna Sri explores a recent Israeli study which suggests that people exposed to genocide are more likely to develop dementia, even when a range of confounders are accounted for.

[read the full story...]

Antipsychotics for schizophrenia: do they provide a longer, healthier life?

michal-parzuchowski-7TWRwDjfGew-unsplash

Paul Heron from the Closing the Gap Network writes his debut blog about a 20‐year cohort study of physical morbidity and mortality in relationship to antipsychotic treatment in a huge group of people with schizophrenia in Finland.

[read the full story...]

Can eating behaviours in childhood predict eating disorder behaviours and diagnoses in adolescence?

borna-bevanda-pe3uN32Q6H4-unsplash

Georgie Parker summarises a longitudinal cohort study which finds that eating behaviours in childhood may predict eating disorder behaviours and diagnoses in adolescence.

[read the full story...]

Risperidone and aripiprazole: genotype, metabolism and dosage

CYP2D6 genotyping before starting treatment might be valuable in clinical practice for individualising risperidone and aripiprazole treatment.

Dolly Sud writes her debut elf blog on a recent retrospective analysis, which compares dose changes of risperidone and aripiprazole with patients’ individual genotype.

[read the full story...]